RedHill Biopharma Files 6-K Report
Ticker: RDHL · Form: 6-K · Filed: Apr 30, 2026 · CIK: 0001553846
| Field | Detail |
|---|---|
| Company | Redhill Biopharma Ltd. (RDHL) |
| Form Type | 6-K |
| Filed Date | Apr 30, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-issuer, regulatory-filing
TL;DR
RHBP filed a 6-K on 4/30/26, standard foreign issuer report.
AI Summary
RedHill Biopharma Ltd. filed a Form 6-K on April 30, 2026. This report is for a foreign issuer and provides information as of the period ending April 30, 2026. The filing includes a 6-K document and a graphic image file.
Why It Matters
This filing indicates ongoing reporting requirements for RedHill Biopharma as a foreign issuer, providing updates to investors and regulators.
Risk Assessment
Risk Level: low — A Form 6-K is a routine filing for foreign issuers and does not typically contain material non-public information that would significantly alter risk.
Key Players & Entities
- RedHill Biopharma Ltd. (company) — Filer
- 0001553846 (company) — CIK Number
- 0001178913-26-002304 (filing_id) — SEC Accession Number
- 2026-04-30 (date) — Filing Date and Period of Report
FAQ
What type of SEC filing is this?
This is a Form 6-K, which is a Report of foreign issuer pursuant to Rules 13a-16 and 15d-16.
Who is the filer of this document?
The filer is RedHill Biopharma Ltd., with CIK number 0001553846.
When was this filing accepted by the SEC?
The filing was accepted on 2026-04-30 at 07:02:46.
What is the period of report for this filing?
The period of report is 2026-04-30.
What are the business and mailing addresses listed for RedHill Biopharma Ltd.?
Both the mailing and business addresses are listed as 21 HA'ARBA'A STREET TEL AVIV L3 64739.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 30, 2026 regarding RedHill Biopharma Ltd. (RDHL).